Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models

• Main Authors: Giovanna Castoldi (Author), Raffaella Carletti (Author), Francesca Barzaghi (Author), Michela Meani (Author), Giovanni Zatti (Author), Gianluca Perseghin (Author), Cira R. T. Di Gioia (Author), Gianpaolo Zerbini (Author)
• Format: Book
• Published: MDPI AG, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of glucose-lowering agents widely used for the treatment of type 2 diabetes mellitus. A number of clinical trials in type 2 diabetic patients with different degrees of renal impairment have clearly demonstrated that SGLT2 inhibitors reduc...